The primary objective of this retrospective study was to investigate the possibility of achieving partial remission (PR) in AS patients treated with anti-TNF-α antagonists, such as adalimumab (ADA), etanercept (ETA) and infliximab (INF), in a real clinical practice setting. Predictors of PR were also evaluated.
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study / Spadaro, Antonio; Lubrano, Ennio; Marchesoni, Antonio; D'Angelo, Salvatore; Ramonda, Roberta; Addimanda, Olga; Perrotta, Fabio Massimo; Olivieri, Ignazio; Punzi, Leonardo; Salvarani, Carlo. - In: RHEUMATOLOGY. - ISSN 1462-0332. - 52:(2013), pp. 1914-1919. [10.1093/rheumatology/ket249]
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study
SALVARANI, CARLO
2013
Abstract
The primary objective of this retrospective study was to investigate the possibility of achieving partial remission (PR) in AS patients treated with anti-TNF-α antagonists, such as adalimumab (ADA), etanercept (ETA) and infliximab (INF), in a real clinical practice setting. Predictors of PR were also evaluated.
| File | Dimensione | Formato | |
|---|---|---|---|
|
rheumatology_2Fket249.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
313.88 kB
Formato
Adobe PDF
|
313.88 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
